a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NNLEX | 28.68 | 0.51 | +1.81% |
Nicholas Limited Edition N | |||
BARDX | 8.30 | 0.03 | +0.36% |
iShares Developed Real Estate Idx Inv A | |||
DISRX | 23.76 | 0.08 | +0.34% |
BNY Mellon International Stock Fund I | |||
GSVPX | 17.63 | N/A | N/A |
Goldman Sachs Small/Mid Cap Value P | |||
SDMGX | 17.79 | -0.04 | -0.22% |
Sit Developing Markets Growth |
A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with ARRY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then ARRY could also see price increases.
Ticker / NAME | Correlation To OCGN | 1D Price Change % | ||
---|---|---|---|---|
OCGN | 100% | -1.92% | ||
ARRY - OCGN | 47% Loosely correlated | -0.63% | ||
AXON - OCGN | 46% Loosely correlated | +3.52% | ||
HRTX - OCGN | 36% Loosely correlated | -5.36% | ||
XNCR - OCGN | 36% Loosely correlated | +1.60% | ||
INZY - OCGN | 35% Loosely correlated | -3.58% | ||
More |